190 related articles for article (PubMed ID: 17089700)
1. Aerosolization potential of cyclodextrins--influence of the operating conditions.
Le VN; Leterme P; Gayot A; Flament MP
PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
[TBL] [Abstract][Full Text] [Related]
2. Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization.
Thi TH; Azaroual N; Flament MP
Eur J Pharm Biopharm; 2009 May; 72(1):214-8. PubMed ID: 19010412
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.
Steckel H; Eskandar F
Eur J Pharm Sci; 2003 Aug; 19(5):443-55. PubMed ID: 12907295
[TBL] [Abstract][Full Text] [Related]
4. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
McCallion ON; Taylor KM; Thomas M; Taylor AJ
Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrins as a potential carrier in drug nebulization.
Evrard B; Bertholet P; Gueders M; Flament MP; Piel G; Delattre L; Gayot A; Leterme P; Foidart JM; Cataldo D
J Control Release; 2004 May; 96(3):403-10. PubMed ID: 15120897
[TBL] [Abstract][Full Text] [Related]
6. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
[TBL] [Abstract][Full Text] [Related]
7. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
[TBL] [Abstract][Full Text] [Related]
9. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
[TBL] [Abstract][Full Text] [Related]
10. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
11. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration.
Phipps PR; Gonda I
Chest; 1990 Jun; 97(6):1327-32. PubMed ID: 2347217
[TBL] [Abstract][Full Text] [Related]
12. Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein.
Steckel H; Eskandar F; Witthohn K
Eur J Pharm Biopharm; 2003 Jul; 56(1):11-21. PubMed ID: 12837476
[TBL] [Abstract][Full Text] [Related]
13. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
[TBL] [Abstract][Full Text] [Related]
14. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
[TBL] [Abstract][Full Text] [Related]
15. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
[TBL] [Abstract][Full Text] [Related]
16. Design principles of liquid nebulization devices currently in use.
Rau JL
Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
[TBL] [Abstract][Full Text] [Related]
17. Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers.
Takanami C; Goto Y
J Aerosol Med; 1990; 3(1):45-52. PubMed ID: 10147674
[TBL] [Abstract][Full Text] [Related]
18. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
[TBL] [Abstract][Full Text] [Related]
19. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
[TBL] [Abstract][Full Text] [Related]
20. Ventilator-integrated jet nebulization systems: tidal volume control and efficiency of synchronization.
Ehrmann S; Lyazidi A; Louis B; Isabey D; Le Pennec D; Brochard L; Apiou-Sbirlea G
Respir Care; 2014 Oct; 59(10):1508-16. PubMed ID: 24917450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
